Vetigenics is an animal health biopharmaceutical company committed to improving canine health through the development of entirely canine, safe and effective antibody-based immunotherapies to treat cancer, infectious disease and other chronic conditions. The company’s founders, Nicola Mason, BVetMed, PhD and Don Siegel MD, PhD of the University of Pennsylvania are internationally recognized leaders in veterinary medicine, immunotherapy, and phage display technology. Their complementary expertise naturally resulted in an unrivalled ability to generate and validate entirely canine antibodies therapeutics.